Johnson & Johnson (BCBA:JNJ)

Market Cap	819.14T +121.3%
Revenue (ttm)	136.80T +6.0%
Net Income	38.93T +90.6%
EPS	16,018.87 +90.5%
Shares Out	n/a
PE Ratio	21.04
Forward PE	20.74
Dividend	277.59 (1.19%)
Ex-Dividend Date	Nov 25, 2025

Volume	6,339
Average Volume	13,698
Open	23,600
Previous Close	23,550
Day's Range	23,220 - 23,860
52-Week Range	11,225 - 24,170
Beta	0.33
RSI	70.73
Earnings Date	Jan 21, 2026

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1886
• Employees: 138,100
• Stock Exchange: Buenos Aires Stock Exchange
• Ticker Symbol: JNJ

Financial Performance

In 2025, Johnson & Johnson's revenue was $94.19 billion, an increase of 6.05% compared to the previous year's $88.82 billion. Earnings were $26.80 billion, an increase of 90.56%.

Financial numbers in USD